L’Oréal Egypt hosted its ninth annual Skin and Hair Summit, drawing over 1,000 leading dermatologists from Egypt and the Middle East. The summit, accredited by the CPD Institute, was held at the Salah El-Din Citadel and focused on the latest developments and innovations in skin and hair care. The summit featured four-panel discussions covering a range of topics, including hair science, acne treatment, hyperpigmentation, and anti-ageing.
Dr Anna Kelly discussed hair science and androgenetic alopecia, while Professor May El Samahy focused on advancements in acne treatment. Professor Samia Essmat led a panel on hyperpigmentation, which saw the announcement of a new La Roche-Posay product. The summit concluded with an interactive anti-ageing session featuring Professor Shady Mahmoud and Dr.
Amin Sharobeem. On the sidelines of the summit , L’Oréal Egypt, through its international brand La Roche-Posay, unveiled its latest skincare innovation: MELAB3, a new serum designed to address localized pigmentation issues such as age spots and post-acne marks. The MELAB3 serum, developed after 18 years of research and 121 scientific studies, is the first dermatological discolouration and dark spot solution powered by MelasylTM with 10% Niacinamide.
The anti-ageing serum visibly reduces a range of skin discolouration, including sunspots, age spots, post-acne marks, and even the most persistent dark spots, with long-lasting results while respecting the natural tone of all skin. “We ar.